
Pro-Dex PDEX
€ 53.45
-2.16%
Quartalsbericht 2025-Q4
hinzugefügt 29.01.2026
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NASDAQ GLOBAL |
Anteile |
3.29 M |
Marktkapitalisierung |
$ 204 M |
EBITDA (LTM) |
$ 11.3 M |
P/E (LTM) |
18.3 |
P/S (LTM) |
2.72 |
EPS (LTM) |
3.06 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
ICU Medical
ICUI
|
$ 128.59 | -0.56 % | $ 3.17 B | Nasdaq Global Select Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 62.8 | 1.7 % | $ 12.5 B | NYSE,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 440.62 | -1.87 % | $ 157 B | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Repro Med Systems
KRMD
|
$ 4.15 | 3.75 % | $ 192 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 68.0 | 1.05 % | $ 40.4 B | NYSE | ||
|
LeMaitre Vascular
LMAT
|
$ 100.1 | -1.07 % | $ 2.27 B | Nasdaq Global Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 178.74 | -0.03 % | $ 9.53 B | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 117.88 | 0.75 % | $ 3.77 B | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Milestone Scientific
MLSS
|
$ 0.38 | -3.07 % | $ 31.2 M | NYSE American | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
electroCore
ECOR
|
$ 5.91 | -3.67 % | $ 50.1 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 23.56 | -0.86 % | $ 3.96 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 61.74 | 3.71 % | $ 2.91 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 63.9 | -0.42 % | $ 207 M | Nasdaq Global Select Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Glaukos Corporation
GKOS
|
$ 139.9 | -2.77 % | $ 6.78 B | NYSE,SPB | ||
|
STERIS plc
STE
|
$ 216.76 | 0.37 % | $ 21.4 B | NYSE,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 32.94 | -0.33 % | $ 1.63 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.73 | -4.23 % | $ 201 M | NYSE American | ||
|
Microbot Medical
MBOT
|
$ 1.74 | - | $ 79.7 M | Nasdaq Global Select Market | ||
|
Teleflex Incorporated
TFX
|
$ 132.42 | -2.09 % | $ 5.91 B | NYSE,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 63.81 | -1.05 % | $ 3.77 B | Nasdaq Global Select Market,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 9.99 | 1.52 % | $ 1.99 B | Nasdaq Global Select Market,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 313.58 | 2.66 % | $ 22.7 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 25.53 | -2.15 % | $ 1.72 B | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.68 | 1.34 % | $ 20.4 M | NYSE American | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 24.52 | 2.17 % | $ 1.17 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.88 | 1.62 % | $ 171 M | NYSE American | ||
|
Baxter International
BAX
|
$ 18.71 | -0.29 % | $ 9.6 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 208.58 | -0.62 % | $ 30.5 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 29.24 | 0.83 % | $ 1.4 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 5.44 | 0.74 % | $ 241 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 11.79 | -0.17 % | $ 482 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 145.2 | -1.18 % | $ 41.8 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.53 | -0.28 % | $ 37.5 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.16 | 2.93 % | $ 232 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 112.98 | 1.11 % | $ 6.35 M | Nasdaq Global Select Market,SPB |